当前位置:首页 - 行情中心 - 信邦制药(002390) - 财务分析 - 资产负债表

信邦制药

(002390)

  

流通市值:70.01亿  总市值:74.45亿
流通股本:18.28亿   总股本:19.44亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金805,982,979.141,058,407,708.4788,348,688.91909,945,351.72
应收票据及应收账款2,965,963,152.242,955,775,344.263,240,512,161.093,156,450,130.91
其中:应收票据90,688,448.886,727,152.5114,381,294.06107,115,930.28
应收账款2,875,274,703.442,869,048,191.763,126,130,867.033,049,334,200.63
应收款项融资70,533,367.8872,721,967.4575,775,920.5188,126,677.69
预付款项243,026,140.74189,832,068.81234,906,044.89272,894,913.62
其他应收款合计320,390,993.67442,825,545.06443,459,468.6454,880,878.93
存货1,000,779,296.711,058,453,586.591,008,646,803.571,063,893,974.42
其他流动资产4,856,484.853,990,979.324,436,162.375,181,189.52
流动资产平衡项目0000
流动资产合计5,411,532,415.235,782,007,199.895,796,085,249.945,951,373,116.81
非流动资产:
其他权益工具投资340,471,682.97343,838,520.67343,838,520.67343,838,520.67
投资性房地产34,999,618.94---
固定资产2,434,354,961.642,482,629,535.852,523,144,387.72,577,261,738.21
在建工程58,062,889.6855,445,068.1536,669,60624,767,406.8
使用权资产25,643,963.5125,239,584.2226,827,353.5729,014,128.79
无形资产180,177,709.91182,952,605.64186,446,982.74200,704,461.8
商誉603,749,295.25603,749,295.25603,749,295.25607,346,640.37
长期待摊费用81,840,623.7683,798,463.1686,895,716.7593,373,607.76
递延所得税资产74,137,989.367,555,105.2367,716,061.2962,245,720.59
非流动资产平衡项目0000
非流动资产合计3,833,438,734.963,845,208,178.173,875,287,923.973,938,552,224.99
资产平衡项目0000
资产总计9,244,971,150.199,627,215,378.069,671,373,173.919,889,925,341.8
流动负债:
短期借款796,285,391.31,126,867,894.011,264,181,949.621,431,966,273.63
应付票据及应付账款903,149,816.21908,415,360.31815,799,234.44874,751,610.74
其中:应付票据248,519,373.44233,736,381.55157,583,794.58238,987,504.41
应付账款654,630,442.77674,678,978.76658,215,439.86635,764,106.33
合同负债27,984,091.2726,016,57530,596,634.7930,165,456.16
应付职工薪酬20,179,958.5413,940,972.2321,261,193.2917,932,520.14
应交税费37,576,838.0936,088,321.4727,473,002.8831,642,555.6
其他应付款合计266,972,961.23326,805,858.06360,671,959.44332,225,328.26
应付股利606,957.57606,957.5727,750,957.57606,957.57
一年内到期的非流动负债4,399,963.983,017,945.482,935,325.132,594,976.65
其他流动负债2,019,914.192,066,928.532,772,125.682,267,949.18
流动负债平衡项目0000
流动负债合计2,058,568,934.812,443,219,855.092,525,691,425.272,723,546,670.36
非流动负债:
租赁负债21,124,303.2620,124,708.2221,069,921.5221,076,629.93
预计负债307,906307,906307,906307,906
递延收益22,039,139.2717,811,708.1717,922,219.9318,357,731.69
递延所得税负债844,246.48---
非流动负债平衡项目0000
非流动负债合计44,315,595.0138,244,322.3939,300,047.4539,742,267.62
负债平衡项目0000
负债合计2,102,884,529.822,481,464,177.482,564,991,472.722,763,288,937.98
所有者权益(或股东权益):
实收资本(或股本)1,943,851,8681,943,851,8681,943,851,8681,943,851,868
资本公积4,402,703,137.584,401,764,938.444,401,764,938.444,401,764,938.44
减:库存股127,491,540.8573,948,536.87--
盈余公积101,022,709.6189,622,876.1989,622,876.1989,622,876.19
未分配利润532,315,149.83503,155,850.94412,602,299.08426,156,734.76
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计6,852,401,324.176,864,446,996.76,847,841,981.716,861,396,417.39
少数股东权益289,685,296.2281,304,203.88258,539,719.48265,239,986.43
股东权益平衡项目0000
股东权益合计7,142,086,620.377,145,751,200.587,106,381,701.197,126,636,403.82
负债和股东权益合计9,244,971,150.199,627,215,378.069,671,373,173.919,889,925,341.8
公告日期2024-04-162023-10-302023-08-292023-04-29
审计意见(境内)标准无保留意见
TOP↑